Zenith Drugs (ZENITHDRUG.NS) Stock Price
Zenith Drugs Price
Over the last 2 years Zenith Drugs grew revenue by 7.9% annually, reaching 1.33 B INR. Earnings per share have grown at 21.1% per year over the last 2 years. For Zenith Drugs, the net margin of 5.4% is up versus 4.3% a few years ago. At today's price the dividend yield works out to roughly 1.23%. The payout ratio is around 9% of earnings.
Zenith Drugs stock price
Zenith Drugs business model & stock analysis
Frequently asked questions about Zenith Drugs
Converted at the current exchange rate, the Zenith Drugs share trades at 0.37 EUR (40.60 INR).
The revenue cannot currently be calculated for Zenith Drugs.
The profit cannot currently be calculated for Zenith Drugs.
The P/E ratio cannot be calculated for Zenith Drugs at the moment.
The P/S cannot be calculated for Zenith Drugs currently.
The Eulerpool Quality Score for Zenith Drugs is 1/10.
The ISIN of Zenith Drugs is INE0QWN01013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Zenith Drugs is ZENITHDRUG.NS. The ticker symbol is used to trade Zenith Drugs shares on the stock exchange.
Zenith Drugs stock
Zenith Drugs Peer Group
All fundamentals and in-depth analysis of Zenith Drugs
Our stock analysis for Zenith Drugs stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zenith Drugs. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.